Transgenic mice with cardiac-specific overexpression of human Rgs5 gene were resistant to cardiac hypertrophy and fibrosis via inhibition of MEK-ERK1/2 signaling [24]. The gene discussed is MAPK3; the disease is cardiac hypertrophy.